MB, Levis & Associates’s Scansource SCSC Stock Holding History

MB, Levis & Associates’s Portfolio SCSC Stock Details SCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-50	Closed	-$2.2K	–	260
2025 Q3	$2.2K	Buy	+50	New	+$2.13K	﹤0.01%	214

Other funds holding SCSC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

MB, Levis & Associates's SCSC Position: Q4 2025 in Review

MB, Levis & Associates sold out of Scansource (SCSC) in Q4 2025, closing a stake of 50 shares — an estimated $2.2K sold.

MB, Levis & Associates first reported a position in SCSC in Q3 2025 and held it in 1 quarter. The position peaked at $2.2K in Q3 2025. 208 funds tracked by Wall St. Rank hold SCSC as of Q4 2025.

MB, Levis & Associates reported no remaining Scansource position as of Q4 2025 after selling out during the quarter.
MB, Levis & Associates sold 50 Scansource shares in Q4 2025, an estimated $2.2K.
MB, Levis & Associates first reported a position in Scansource in Q3 2025 and held it in 1 quarter.
MB, Levis & Associates's Scansource position peaked at $2.2K in Q3 2025.
208 funds tracked by Wall St. Rank held Scansource as of Q4 2025.

Based on MB, Levis & Associates's 13F filing for Q4 2025, filed 14 Jan 2026.